- Start
- EGFR-Directed Therapy in Lung Cancer
EGFR-Directed Therapy in Lung Cancer
Angebote / Angebote:
This Element describes the structural biology and pathophysiology of EGFR-mutant NSCLC and describes past, current, and future treatment options in different settings. It discusses the biology and recently approved treatment for EGFR-exon 20 insertion mutation and the treatment for the uncommon mutations.
Folgt in ca. 15 Arbeitstagen
Preis
31,50 CHFVerfügbarkeit:
LieferbarArtikel, die Sie kürzlich angesehen haben
Lieferbar in ca. 10-20 Arbeitstagen
